May 10, 2016 / 11:17 AM / in a year

BRIEF-Revive to start Phase 2b trial in gout after access to required capital

May 10 (Reuters) - Revive Therapeutics Ltd

* Says will start its Phase 2B trial in gout when it has access to capital necessary to fund trial

* Over last several months, has taken necessary steps to reduce its monthly cash burn rate and streamline its operations Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below